$ACT Recent News Staples awash in red; eBay up as Icahn

New Post Public Reply Private Reply Replies (0) Message Board

Mar 12, 2014 at 12:44 PM

$ACT Recent News

Staples awash in red; eBay up as Icahn posts new letter 4:09 p.m. March 6, 2014 - Victor Reklaitis
Icahn Enterprises reports profit up 144% in 2013 10:22 a.m. March 3, 2014 - MarketWatch
Citadel hedge fund’s recent moves 11:12 a.m. Feb. 25, 2014 - Insider Monkey
Stocks rally; S&P 500 ends right below record 4:45 p.m. Feb. 24, 2014 - Victor Reklaitis
U.S. stock market is starting to ride a tech M&A wave 5:31 a.m. Feb. 24, 2014 - Wallace Witkowski
Actavis continues hot streak with better-than-expected earnings 11:21 a.m. Feb. 20, 2014 - blogs.marketwatch.com
Actavis swings to loss on charges, write-downs 8:03 a.m. Feb. 20, 2014 - MarketWatch.com
Pharma megamergers bring higher profits, better returns, study says 1:59 p.m. Feb. 19, 2014 - blogs.marketwatch.com
Actavis, Forest shares continue their climb in aftermath of $25 billion deal 11:03 a.m. Feb. 19, 2014 - blogs.marketwatch.com
U.S. stocks edge up; Nasdaq gains for 8th day in a row 4:38 p.m. Feb. 18, 2014 - Anora Mahmudova
Forest Laboratories, Actavis surge on buyout deal 4:10 p.m. Feb. 18, 2014 - Ben Eisen
S&P 500, Nasdaq extend win streaks but Dow dips: stock market live blog recap 4:06 p.m. Feb. 18, 2014 - blogs.marketwatch.com
Forest buyout may not spell the end of dealmaking for Actavis 3:00 p.m. Feb. 18, 2014 - blogs.marketwatch.com
Pharma ETFs pop on the Actavis-Forest deal 2:07 p.m. Feb. 18, 2014 - blogs.marketwatch.com
Investors drive up price of Actavis-Forest deal 11:14 a.m. Feb. 18, 2014 - blogs.marketwatch.com
Actavis shares jump 7.8% on Forest Lab deal 9:35 a.m. Feb. 18, 2014 - Sue Chang
U.S. stock futures trim rise; Forest Labs soars 9:14 a.m. Feb. 18, 2014 - Sara Sjolin
Actavis-Forest Labs is play on changes in health care 9:06 a.m. Feb. 18, 2014 - Dana Mattioli
Actavis confirms $25 bln Forest Labs acquistion 7:15 a.m. Feb. 18, 2014 - Sara Sjolin
Actavis shares climb 10% on deal for Forest Labs 7:12 a.m. Feb. 18, 2014 - Silvia Ascarelli

Greenberg: What You May Have Missed 9:33 a.m. Today - TheStreet.com
How To Invest: Seek Stock Ideas In Sector Leaders 4:23 p.m. March 11, 2014 - Investors Business Daily
Actavis PLC (ACT): Today's Featured Drugs Laggard 5:01 p.m. March 10, 2014 - TheStreet.com
3 Stocks Underperforming Today In The Drugs Industry 1:04 p.m. March 10, 2014 - TheStreet.com
Forest Labs/Adamas Seek FDA Approval - Analyst Blog 5:00 p.m. March 7, 2014 - Zacks.com
Highflying Drug, Biotech Stocks Take Rare Drubbing 4:49 p.m. March 7, 2014 - Investors Business Daily
Merck KGaA Misses 2013 Earnings & Rev Ests - Analyst Blog 10:30 a.m. March 7, 2014 - Zacks.com
Columbia Labs: You did what? 9:30 a.m. March 7, 2014 - Seeking Alpha
Columbia Labs buys back shares 9:30 a.m. March 7, 2014 - Seeking Alpha
Biotech Stocks to Buy After the Pullback 8:18 a.m. March 7, 2014 - 247WallSt.com
Vansen Pharma Inc. appoints Ali Moghaddam to its Board of Advisors 10:47 a.m. March 6, 2014 - CNW Group
Vansen Pharma Inc. appoints Ali Moghaddam to its Board of Advisors 8:30 a.m. March 6, 2014 - CNW Group
Teva Up on FDA Nod for Generic Evista - Analyst Blog 4:06 p.m. March 5, 2014 - Zacks.com
3 Stocks Pushing The Drugs Industry Downward 12:02 p.m. March 5, 2014 - TheStreet.com
Winning Stock Sectors for Tuesday, March 4 12:15 a.m. March 5, 2014 - WallStreetSectorSelector
Precious Metals, Health Care Led Mutual Funds In Feb. 5:21 p.m. March 4, 2014 - Investors Business Daily
Forest Labs Seeks Bystolic-Diovan Approval - Analyst Blog 5:20 p.m. March 4, 2014 - Zacks.com
Top Mutual Funds Add To Health Care, Leisure And Banks 5:20 p.m. March 4, 2014 - Investors Business Daily
Drugmakers Actavis, Biogen, Valeant Hold Near Highs 4:13 p.m. March 4, 2014 - Investors Business Daily
Pernix to Market Osmotica's Khedezla - Analyst Blog 5:30 p.m. March 3, 2014 - Zacks.com

Columbia Laboratories Repurchases 1.4 Million Shares of Common Stock from Actavis 6:50 a.m. March 7, 2014 - PR Newswire - PRF
Actavis to Present at Barclays Global Healthcare Conference 8:00 a.m. March 4, 2014 - PR Newswire - PRF
Actavis Confirms Generic Colcrys® Patent Challenge 4:05 p.m. Feb. 28, 2014 - PR Newswire - PRF
Actavis Confirms Generic Multaq® Patent Challenge 8:00 a.m. Feb. 28, 2014 - PR Newswire - PRF
Actavis Net Revenue Increases 59% to $2.779 Billion in Fourth Quarter 2013; Non-GAAP EPS Increases 99% to $3.17 7:00 a.m. Feb. 20, 2014 - PR Newswire - PRF
Actavis to Present at Citi's 2014 Global Healthcare Conference 4:25 p.m. Feb. 19, 2014 - PR Newswire - PRF
Critical Alerts For Actavis, athenahealth, Seattle Genetics, JP Morgan Chase, and SodaStream Released By InvestorsObserver 9:31 a.m. Feb. 19, 2014 - PR Newswire - PRF
Actavis to buy Forest Labs for $25B and GT Advanced Tech acquires exclusive rights from Kyma Tech 12:31 a.m. Feb. 19, 2014 - ACCESSWIRE
Acquisition of Forest Laboratories, Inc. by Actavis plc May Not Be in Shareholders' Best Interests 9:02 p.m. Feb. 18, 2014 - PR Newswire - PRF
Actavis to Cancel Q4 and FY 2013 Earnings Call Previously Scheduled for Thursday, February 20, 2014 5:13 p.m. Feb. 18, 2014 - PR Newswire - PRF
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Forest Laboratories, Inc. Stockholders 5:01 p.m. Feb. 18, 2014 - BusinessWire - BZX
Fitch Affirms Actavis at 'BBB-' on Forest Labs Acquisition; Outlook Stable 2:52 p.m. Feb. 18, 2014 - BusinessWire - BZX
FOREST SHAREHOLDERS NOTICE:Johnson & Weaver, LLP Announces Investigation of the Forest Laboratories, Inc. Proposed Acquisition by Actavis plc 9:43 a.m. Feb. 18, 2014 - BusinessWire - BZX
INVESTOR BUYOUT ALERT - Offer to Acquire Forest Laboratories - Shareholder Rights Law Firm Tripp Levy PLLC Seeks Higher Price And More Information For Shareholders 8:00 a.m. Feb. 18, 2014 - PR Newswire - PRF
Actavis to Acquire Forest Laboratories, Inc. for ~$25 Billion in an Equity and Cash Transaction 7:00 a.m. Feb. 18, 2014 - BusinessWire - BZX
Actavis to Acquire Forest Laboratories, Inc. for ~$25 Billion in an Equity and Cash Transaction 7:00 a.m. Feb. 18, 2014 - PR Newswire - PRF
Actavis to Host Fourth Quarter 2013 Earnings Conference Call and Webcast 8:00 a.m. Feb. 11, 2014 - PR Newswire - PRF
Actavis Confirms Generic Treanda® Patent Challenge 8:00 a.m. Feb. 4, 2014 - PR Newswire - PRF
Actavis Presents Outlook for Continued Long-Term Growth 7:15 a.m. Jan. 31, 2014 - PR Newswire - PRF
Actavis Announces Refocused Global Business Structure to Maximize Evolution into Global Specialty Pharmaceuticals Leadership 7:00 a.m. Jan. 31, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

IASLC Boosts Global Thoracic Cancer Collaboration

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

SMPL Faces Legal Drama: What Investors Need to Know

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

PathoSearch: A New Era in Pathology With Visual Search

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

OneOdio Showcases Innovation at IFA 2026 in Berlin

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

Ajman Spotlights Tourism at Arabian Travel Market 2026

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Pizza: The Unlikely Symbol of Universal Togetherness

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

ARTiSTORY's Strategic Advance in Cultural IP Licensing

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Larry Ellison's Moves Signal Confidence in Oracle's Future

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...